Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Otol Neurotol. 2019 Oct;40(9):e928–e937. doi: 10.1097/MAO.0000000000002341

Table 2: Baseline differences between response groups.

Mean and standard deviations of demographic features, ratings, and balance testing tabulated according to best treatment selection.

Occipital Vermis Non-
Responder
ANOVA Post hoc Bonferroni test
Clinical F (2,22) p value Occ vs Vermis Occ vs NR Vermis vs NR
Age of onset 52.5 [12.1] 52.3 [11.6] 40.2 [9.2] 2.68 0.0909
Age at study 55.1 [11.5] 53.6 [11.5] 44.7 [13.5] 1.57 0.2297
Duration (mon) 25.2 [23.7] 18.9 [7.2] 52.8 [51.7] 2.6 0.0966
Ratings
DHIT* 46.2 [13.7] 51.1 [13.0] 52.0 [11.3] 0.51 0.6095
MBRS* 4.6 [1.3] 5.2 [0.83] 4.7 [1.5] 0.73 0.4941
HADA* 6.2 [3.3] 6.3 [3.7] 7.8 [4.8] 0.43 0.6565
HADD* 7.0 [3.4] 8.0 [3.2] 8.5 [4.3] 0.37 0.6931
Balance
Feet together^ 98.8 [3.5] 94.9 [9.6] 99.1 [2.0] 1.19 0.3219
Tandem left^ 77.7 [30.3] 58.0 [36.0] 83.7 [10.0] 1.68 0.2093
Tandem right^ 85.1 [18.7] 48.7 [30.5] 76.4 [24.8] 5.34 0.0129 (−36.4) p=0.013 (−8.7) p=1.0 (+27.7) p=0.139

NR= Non-responder; mon= months; DHIT= Dizziness Handicap Inventory; MBRS= Mal de Debarquement Balance Rating Scale; HADA= Hospital Anxiety and Depression Scale Anxiety subscale; HADD=Hospital Anxiety and Depression Scale Depression subscale

^

higher scores represent better balance